TUMOUR BIOMARKER AND PLASMA TIME COURSE DATA FROM ABIGAIL, A PHASE II STUDY OF 1ST-LINE BEVACIZUMAB plus CHEMOTHERAPY IN ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER (NS-NSCLC)

Resource

Ann. Oncol., 23, 405-405

Journal

Ann. Oncol.

Journal Issue

23

Pages

405-405

Date Issued

2012

Date

2012

Author(s)

Reck, M.

Gorbunova, V. A.

Juhasz, E.

Szima, B.

Orlov, S.

Yu, C.

Pallaud, C.

Scherer, S. J.

Archer, V.

Mok, T. S. K.

URI

http://ntur.lib.ntu.edu.tw//handle/246246/259085

SDGs

[SDGs]SDG3

File(s)

Name

index.html

Size

23.1 KB

Format

HTML

Checksum

(MD5):a30ffc2eaddc7dfac27231527fad7562